The study revealed that the mitochondrial division inhibitor-1 (mdivi-1) increases the sensitivity of ovarian cancer cells to cell surface ligands such as FAS, TRAIL, and TNF-alpha [67]. Here, TNFSF10 is linked to ovarian cancer.